What the ‘One Nation, Overcharged’ Campaign Aims to Achieve
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise…
What the ‘One Nation, Overcharged’ Campaign Aims to Achieve
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs. The post What the ‘One Nation, Overcharged’ Campaign Aims to Achieve appeared first on MedCity News.
Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer…
CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery
CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery appeared first on MedCity…
Healthcare Economist Weekly Reader
FDA accepts 1st In Silico Drug Development Tool.Why GLP-1’s got more affordable.BALANCE after CMS GLP-1 decision.How to socialize scientific ideas in the age of AI.Mapping the Ebola outbreak.1985-2023: MIT’s faculty grew 9%…Administrative staff grew 189%
Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices
MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices…
Elimination of Federal Diversity Initiatives: Updates and Current Status
This issue brief provides an update on the status of the Trump administration’s actions to eliminate DEI-related initiatives and the impact on racial health disparities.
Crothall Healthcare EVS Team Member Recognized as “Team Member of the Year” at Allegheny Health Network
Every morning, Crothall Healthcare Environmental Services (EVS) team member, Lynn Bennett, introduces herself to patients with a warm greeting and asks, “Is there anything specific you need or anything else that I can do for you today?” Known for her commitment to patients, Lynn was recently honored with the “Team Member of the Year” award…
The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing
Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded. The post The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing appeared…
Kill the Clipboard Tax
Replacing a paper clipboard with a QR code on your phone doesn’t kill the clipboard; it’s just a better clipboard. Why? The burden is still on the patient. It’s the digital version of carrying a manila folder of records across town. This is a half-measure. It’s not true interoperability. The post Kill the Clipboard Tax appeared…
AI in Drug Discovery: Surveying the Breadth of the Challenges
AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post…
